COROMANDEL - Fundamental Analysis: Financial Health & Valuation
← Back to ListKey Parameters
⭐ Fundamental Rating: 3.0
✅ Positive
Coromandel’s robust revenue growth driven by strong PAT numbers in the last quarter suggests operational effectiveness and market demand for its products. The company exhibits a healthy ROCE of 24.6% indicating efficient capital utilization and profitability.
⚠️ Limitation
The exceptionally high P/E ratio of 31.3, coupled with a PEG ratio of 348, raises concerns about overvaluation relative to earnings growth expectations. Furthermore, the industry average PE of 16.1 suggests that Coromandel is trading at a premium.
📉 Company Negative News
Recent news indicates a decline in profits due to rising commodity prices, prompting analysts to advise investors on potential actions. This suggests underlying inflationary pressures impacting profitability despite revenue growth.
📈 Company Positive News
None found
🏭 Industry
The fertilizer and agri-inputs industry is currently influenced by global commodity price fluctuations and seasonal demand patterns, presenting both opportunities and challenges for companies like Coromandel. Continued government support and farmer sentiment play a key role in the sector’s performance.
🧾 Conclusion
We recommend an entry zone around 1850 ₹, representing a potential undervaluation considering its strong recent performance and robust profitability metrics, anticipating a correction from current levels. Long-term holding guidance suggests focusing on the company's ability to navigate commodity price volatility and capitalize on agricultural demand trends. Ultimately, Coromandel represents a moderate buy with continued monitoring of input costs and market dynamics.